After updating fans on how she’s approaching postpartum fitness for the third time around, Cardi B gave an update on her butt injection reversal.

In a recent Instagram live, the rapper and mother of three, who gave birth in September, shared that she went under the knife earlier this 12 months.

“In January, right after filming ‘Like What,’ I went into surgery. I had a few more injections removed from my butt. Because, you know, it takes a round to remove butt injections. I had several injections removed from my butt. I also went to get treatment for some things related to fibrosis,” Cardi said, per People Magazine.

The “Bongos” rapper said during a previous Instagram Live event in December 2022 that she had 95 percent of previously injected biopolymers removed from her buttocks in August. Biopolymers are the silicone injections Cardi was talking about GQ got into the basement in 2014 for $800.

However, Cardi B isn’t the only one that has had cosmetic surgery reversed. Several famous women, including Blac Chyna, Ayesha Curry and SZA, have also recently spoken out about having their teeth extracted and reversing the procedure. Plastic surgeons are also noticing a major change in patients’ desires.

According to the latest report prepared by American Society of Plastic Surgery“In 2023, there has been a continued movement towards a more natural and athletic silhouette.” The organization has named the latest trendy aesthetic “Ballet Body.”

Featured Stories

More and more patients are choosing procedures aimed toward “slimming” and reversing the Brazilian butt lift and extreme augmentations which have turn out to be fashionable over the last decade or more. The organization said liposuction remained the most in-demand procedure last 12 months, with almost 350,000 procedures performed, a seven percent increase over 2022. While breast augmentation saw a two percent increase and breast lift a seven percent increase, implant removals breasts increased by nine percent.

Trends in body aesthetics are consistently changing. This data comes as the availability and use of GLP-1 drugs comparable to Ozempic and Wegovy have increased, which many individuals in Hollywood and beyond have turned to in large numbers for his or her weight reduction potential. Experts and doctors agree that the growing popularity of drugs is changing trends.

In an interview with the Washington Post, a dietitian Nyemb-Diopa monkey stated that they felt that society was “going backwards”.

“Women’s bodies in society are products, and like all products on the market, they go through a cycle: starting, then maturing,” Nyemb-Diop said publication. “And I think the ‘BBL body’ was mature.”

She added: “The cycle was ready for the introduction of another body – and at the same time, Ozempic was there.”

October is breast cancer awareness month. Black women are roughly 40% more more likely to die from breast cancer than white women and are more likely than white women to be diagnosed with breast cancer at younger ages, in later stages, and for more aggressive types of breast cancer.

Earlier this month US Food and Drug Administration issued a final rule that requires summaries of mammography results, including a press release of breast density, to be prepared at the start. This rule could save lives within the Black community because Black women are inclined to have denser breast tissue than white women, which might increase the risk of developing breast cancer and make it harder to identify early symptoms on a mammogram.

Susan G CommentsThe world’s leading breast cancer organization issued a press release on the new ruling: “Knowledge is power, and all women can now have informed conversations with their doctors about the right screening plan for them based on the factors that influence their risk of breast cancer.” including breast density,” Molly Guthrie, vp of policy and advocacy.

“Knowledge is power, and all women can now have informed conversations with their health care providers about the screening plan that is right for them based on factors that influence breast cancer risk, including breast density,” said Molly Guthrie, vp of policy and advocacy at Susan G. Komen. “This may mean that additional tests are recommended to accurately detect breast cancer.”

Breast density is a mammogram measurement of fibrous and glandular tissue, including the lobules and ducts that produce and transport milk, in comparison with fatty tissue within the breast. Dense breasts are common, affecting roughly 40-50% of U.S. women aged 40-74. However, breast density is just one factor that affects a girl’s risk of breast cancer. Age, gender, genetics, family health history and lifestyle aspects all play a big role in an individual’s overall risk. Women with very dense breasts are 4-5 times more more likely to develop breast cancer, and dense breast tissue can hide lumps on mammograms. Komen encourages women to refer to their health care providers about their breast density and whether additional breast imaging could also be appropriate for them.

By September 10, 2024, mammogram reports must include an assessment of breast density. The reports will include general findings – the breasts are dense or the breasts are not dense – and extra details concerning the density level:

• Breasts are almost completely fatty (not dense)
• Breasts have scattered areas of fibroglandular density (not dense)
• Breasts are heterogeneously dense, which can obscure small masses (dense)
• Breasts are extremely dense, which reduces the sensitivity of mammography (dense)

Thanks to the Affordable Care Act (ACA), tens of millions of people have universal access to annual mammograms starting at age 40, without having to share the price for the patient. However, let’s assume that breast imaging is required along with screening mammography. When this happens, patients often face out-of-pocket costs of lots of and even hundreds of dollars, which poses a big financial barrier to accessing the care they need.

“We want everyone to know that dense breast tissue itself does not require additional imaging – it is just one risk factor for breast cancer,” Guthrie added. “For those who need imaging beyond mammography, out-of-pocket costs are often a barrier. That’s why we have advocated for state and federal legislation to eliminate these expenses. We have the technology to detect breast cancer earlier and save lives, and financial barriers should not stand in the way. It is crucial to understand and affordably access the breast imaging tests they need based on their individual risk.”

“The new federal breast density regulations provide women across the United States with meaningful and more consistent information concerning the density of their breasts. Women with very dense breasts are 4-5 times more more likely to develop breast cancer than women with fatty breasts, and a few studies show that black women are more more likely to have dense breasts. Breast cancer health disparities have a profound impact on Black women, and having more information may help women speak up for themselves and have informed conversations with their healthcare providers. Susan G. Komen encourages women to refer to their health care providers about breast density, in addition to their risk of developing breast cancer, and to contemplate which breast imaging test is correct for them,” said Natasha Mmeje, director of community education and outreach at Susan G. Komem.

The Susan G. Komen Center for Public Policy is working with state and federal lawmakers to pass laws that may eliminate out-of-pocket spending on imaging tests beyond screening mammography. So far 26 states have eliminated out-of-pocket costs patients covered by state medical health insurance plans for diagnostics and/or additional imaging tests. At the federal level Access to the act on breast cancer diagnosis has been introduced within the U.S. House of Representatives and Senate, but is unlikely to be passed on this Congress. Komen calls for legislative motion to remove financial and administrative barriers to breast imaging, ensuring all patients can follow advisable screening guidelines based on their risk.

Additionally, Komen’s ongoing health equity initiative within the Black community, Stand for HER. This health equity revolution is a targeted initiative to scale back breast cancer disparities among the many Black community by 25%, starting in U.S. metropolitan areas where disparities are highest; read more Here.

Black doctors and other people of color are much more likely to simply accept Medicaid as a type of payment than white doctors, in accordance with newly published research, underscoring the necessity to expand Medicaid and Medicare.

According to research published in , people from communities “underrepresented in medicine” were more more likely to achieve this. meeting with Medicaid beneficiaries than their white counterparts. While the study acknowledged its own limitations, it also pointed to the necessity for greater diversity within the medical field.

According to the study, the study indicates that Black and Latino physicians are 60% and 40% more likely, respectively, to have contact with Medicaid beneficiaries, and likewise generally have greater representation of those patients of their patient profiles than white physicians. The study also highlights the necessity for greater diversity within the medical field, which has come under attack from conservative groups after the Supreme Court ruled affirmative motion unconstitutional in 2023.

Additionally, the study confirms previous research that found that physicians from underrepresented populations were more more likely to open family medicine practices in communities of color which have not traditionally had access to high-quality health care.

According to the article’s lead writer, Anushree Vichare, the article doesn’t argue that “we want minority physicians to shoulder all the responsibility for working in underserved areas and caring for Medicaid patients.”

Instead, Vichare said special attention needs to be paid to retaining and developing talent within the medical field.

“Our research suggests that Black and Latino family medicine physicians play a critical role in providing health care to people living in marginalized communities. Building a more diverse and representative health care workforce leads to better health care for all and is also necessary from a social justice perspective.” Vichare said.

Vichare continued: “We, as a society, must make sure that those underrepresented in medicine have fair and equal opportunities to pursue medical degrees. It can be essential to support an inclusive culture in healthcare institutions that values ​​diversity and promotes the retention and skilled development of diverse staff.

Despite these comments, Vichare emphasized that each one physicians, not only those from underrepresented backgrounds, need support to thrive while treating their patients.

“For clinicians, recruitment is the first step. This is a very critical step. But we also need to ensure that they invest in retention and development and help all clinicians develop while ensuring fair and equal opportunities. Investments in other workforces can be truly critical, but at the same time they should cover the entire professional continuum,” Vichare said.

Post views: 131